News

Immune cells engineered to attack childhood cancers were able to eradicate different types of pediatric tumors in mice, according to a new study.
Read more on Science Daily »
A mechanism which drives leukaemia cell growth has been discovered by researchers, who believe their findings could help to inform new strategies when it comes to treating the cancer.
Read more on Science Daily »
New research has identified a backup for an important biological system -- the hematopoietic system, whose adult stem cells constantly replenish the body's blood supply.
Read more on Science Daily »
New research means more than 90 percent of the most common cases of childhood cancer can now be classified by subtype, an advance likely to fuel precision medicine.
Read more on Science Daily »
Oncologists have found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug is taken as a pill once a day -- much more convenient than the…
Read more on Science Daily »
Today, the American Society of Hematology submitted feedback on draft recommendations for reforming Maintenance of Certification (MOC) to a commission appointed by the American Board of Medical Specialties (ABMS) and other entities.
Read more on American Society of Hematology »
Researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Read more on Science Daily »
Scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years. When a key protein responsible for leukemia, MLL, is stabilized, it slows the progression of…
Read more on Science Daily »
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report…
Read more on American Society of Hematology »
The editors of Blood, the most-cited journal in hematology, have selected the top manuscripts of 2018.
Read more on American Society of Hematology »
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists have found that this compound, which targets an essential…
Read more on Science Daily »
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no approved treatments.
Read more on American Society of Hematology »
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.
Read more on Science Daily »
Researchers recently discovered that by testing the level of NER (nucleotide excision repair) gene expression, pediatric oncologists can determine the likelihood of early relapse (less than three years) in their acute lymphoblastic leukemia (ALL) patients.
Read more on Science Daily »
Today, Congress passed the bi-partisan Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018.
Read more on American Society of Hematology »
A physicist hopes to improve cancer detection with a new and novel class of nanomaterials.
Read more on Science Daily »
Rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia. Research on the differing drug response patterns of leukemia stem cells and blasts may show why some attempts to…
Read more on Science Daily »
Israeli scientists and physicians develop a new technology for profiling the unique genetic makeup of myeloma tumor cells that will allow better diagnosis and treatment.
Read more on Science Daily »
Researchers have discovered that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell's ability to respond to and repair DNA damage, a known origin of cancer.
Read more on Science Daily »
Researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy (CAR-T cell therapy) in treating cancer.
Read more on Science Daily »